Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak
- PMID: 3485275
Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak
Abstract
In 1982, an outbreak of Haemophilus influenzae type b disease occurred in a 379-member Amish community. In an attempt to control the outbreak after the occurrence of the second case of disease, we investigated the combination of (1) rifampin chemoprophylaxis of all carriers of H influenzae type b and their household contacts from 1 month to 5 years of age and (2) H influenzae type b polysaccharide vaccine immunoprophylaxis of all community members 12 months of age and older. Despite our intervention, two additional cases of bacteremic H influenzae type b disease occurred in the ensuing 5 months, one in a 22-month-old infant who had been immunized at 19 months of age and the other in a child who had not been immunized because she was younger than 12 months of age. The outbreak ended following rifampin prophylaxis of all community members younger than 15 years of age. All of the children with disease were genetically related to one another, and three of the four were inbred. However, analysis of their coancestry revealed that neither the average level of kinship nor the average inbreeding level of the affected children differed significantly from those of the other children in the community. Furthermore, none of the four children with disease shared a human leukocyte antigen haplotype. Our observations suggest that inbreeding was not a risk factor in this community.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.Pediatrics. 1987 Sep;80(3):319-29. Pediatrics. 1987. PMID: 3114708
-
Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.Pediatrics. 1980 Jul;66(1):5-8. Pediatrics. 1980. PMID: 6967587
-
Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.Pediatrics. 1990 Apr;85(4 Pt 2):643-7. Pediatrics. 1990. PMID: 2179854 Review.
-
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.Pediatrics. 1977 Nov;60(5):730-7. Pediatrics. 1977. PMID: 335348 Clinical Trial.
-
Passive immunization for infection with Haemophilus influenzae type b.Pediatrics. 1990 Apr;85(4 Pt 2):662-6. Pediatrics. 1990. PMID: 2179857 Review.
Cited by
-
Lipopolysaccharide gel profiles of Haemophilus influenzae type b are not stable epidemiologic markers.J Clin Microbiol. 1986 Aug;24(2):223-7. doi: 10.1128/jcm.24.2.223-227.1986. J Clin Microbiol. 1986. PMID: 3489005 Free PMC article.
-
A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.J Clin Invest. 1990 Apr;85(4):1158-66. doi: 10.1172/JCI114548. J Clin Invest. 1990. PMID: 2318971 Free PMC article.
-
Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.Infect Immun. 2003 Jan;71(1):275-86. doi: 10.1128/IAI.71.1.275-286.2003. Infect Immun. 2003. PMID: 12496177 Free PMC article.
-
Major subtypes of invasive Haemophilus influenzae from 1983 to 1985 in Atlanta, Ga.J Clin Microbiol. 1990 May;28(5):833-6. doi: 10.1128/jcm.28.5.833-836.1990. J Clin Microbiol. 1990. PMID: 2191007 Free PMC article.
-
Separation of Haemophilus influenzae type b subtypes by numerical analysis.J Clin Microbiol. 1987 Aug;25(8):1476-80. doi: 10.1128/jcm.25.8.1476-1480.1987. J Clin Microbiol. 1987. PMID: 3497945 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical